Title of article
Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan
Author/Authors
Akemi Tomoda، نويسنده , , Keiko Nomura، نويسنده , , Seiji Shiraishi، نويسنده , , Akinobu Hamada، نويسنده , , Takafumi Ohmura، نويسنده , , Mitsuaki Hosoya، نويسنده , , Teruhisa Miike، نويسنده , , Yukio Sawaishi، نويسنده , , Hiroshi Kimura، نويسنده , , Hiroshi Takashima، نويسنده , , Yoshihiro Tohda، نويسنده , , Kenji Mori، نويسنده , , Zenichiro Kato، نويسنده , , Ai Fukushima، نويسنده , , Hisanori Nishio، نويسنده , , Akio Nezu، نويسنده , , Kenji Nihei، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2003
Pages
4
From page
514
To page
517
Abstract
Ten patients with SSPE were surveyed during the last 4 years from the viewpoint of clinical safety for use of ribavirin therapy. Although effectiveness varied among cases, they were all treated safely with intraventricular ribavirin. This study suggests that treatment is safe and well-tolerated.
Keywords
Ribavirin , Subacute sclerosing panencephalitis (SSPE) , Interferon (IFN)
Journal title
Brain and Development
Serial Year
2003
Journal title
Brain and Development
Record number
494662
Link To Document